Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Omeros reported $-39975000 in EBITDA for its fiscal quarter ending in December of 2022.

Ebitda Change
Alnylam Pharmaceuticals ALNY:US USD -135742000 38.56M
BioMarin Pharmaceutical BMRN:US USD 87.87M 87.82M
Gilead Sciences GILD:US USD 2.24B 456M
Immunic Inc. VTL:US USD -27219000 2.88M
Insmed INSM:US USD -154469000 4.76M
Intercept Pharmaceuticals ICPT:US USD -31543000 13.66M
Knight Therapeutics Inc GUD:CN CAD 18.72M 7.18M
MacroGenics MGNX:US USD -35443000 50.66M
Mirati Therapeutics MRTX:US USD -192748000 18.08M
Pacira PCRX:US USD 28.64M 16.13M
Pfizer PFE:US USD 8.01B 683M
Sangamo BioSciences SGMO:US USD 80.09M 132.14M
Sarepta Therapeutics SRPT:US USD -126783000 30.5M
United Therapeutics UTHR:US USD 297.7M 97.7M
Vertex Pharmaceuticals VRTX:US USD 817.8M 254.1M
Xoma XOMA:US USD -9944000 3.83M